Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma

類似資料

• Close Temporal Relationship Between Onset of Cancer and Scleroderma in Patients with RNA Polymerase I/III Antibodies
  著者:: Shah, Ami A., 等
  出版事項: (2010)
• Anti-IFI16 antibodies in scleroderma are associated with digital gangrene
  著者:: McMahan, Zsuzsanna H., 等
  出版事項: (2016)
• Examination of autoantibody status and clinical features that associate with cancer risk and cancer-associated scleroderma
  著者:: Shah, Ami A., 等
  出版事項: (2015)
• Anti-β2 glycoprotein I antibodies are independently associated with macrovascular disease and mortality in scleroderma patients
  著者:: Boin, Francesco, 等
  出版事項: (2009)
• Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial Hypertension
  著者:: Shah, Ami A., 等
  出版事項: (2009)